FUKOKU MUTUAL LIFE INSURANCE Co Has $12.65 Million Position in CME Group Inc. $CME

Posted by Francis Steltz on May 29th, 2026

FUKOKU MUTUAL LIFE INSURANCE Co boosted its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2,935.8% in the fourth quarter, Holdings Channel reports. The firm owned 46,327 shares of the financial services provider’s stock after purchasing an additional 44,801 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in CME Group were worth $12,651,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the company. Truist Financial Corp boosted its holdings in shares of CME Group by 8.9% in the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after buying an additional 5,773 shares during the period. Ashton Thomas Private Wealth LLC boosted its holdings in shares of CME Group by 78.8% in the third quarter. Ashton Thomas Private Wealth LLC now owns 13,281 shares of the financial services provider’s stock valued at $3,588,000 after buying an additional 5,855 shares during the period. SG Americas Securities LLC boosted its holdings in shares of CME Group by 345.2% in the fourth quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock valued at $64,965,000 after buying an additional 184,459 shares during the period. Dover Advisors LLC boosted its holdings in shares of CME Group by 95.5% in the third quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider’s stock valued at $1,512,000 after buying an additional 2,734 shares during the period. Finally, Keybank National Association OH boosted its holdings in shares of CME Group by 15.4% in the third quarter. Keybank National Association OH now owns 153,625 shares of the financial services provider’s stock valued at $41,508,000 after buying an additional 20,477 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on CME. The Goldman Sachs Group reduced their price target on shares of CME Group from $275.00 to $267.00 and set a “sell” rating for the company in a report on Thursday, April 23rd. Rothschild & Co Redburn reduced their price target on shares of CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a report on Monday, April 27th. Argus reiterated a “hold” rating on shares of CME Group in a report on Wednesday, March 4th. Piper Sandler upped their price target on shares of CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a report on Wednesday, April 15th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group has a consensus rating of “Moderate Buy” and a consensus price target of $305.29.

Read Our Latest Report on CME Group

Insiders Place Their Bets

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the company’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel directly owned 7,192 shares in the company, valued at $2,397,597.04. This trade represents a 31.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 44,044 shares of company stock valued at $13,297,507. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Performance

NASDAQ CME opened at $277.42 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm’s fifty day moving average price is $293.99 and its two-hundred day moving average price is $289.62. CME Group Inc. has a 1 year low of $257.17 and a 1 year high of $329.16. The firm has a market capitalization of $100.53 billion, a P/E ratio of 23.67, a price-to-earnings-growth ratio of 3.12 and a beta of 0.23.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the prior year, the firm posted $2.80 earnings per share. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, research analysts anticipate that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s dividend payout ratio is 44.37%.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.